Prostate Cancer - Results from #20380

Iodine-125 prostate seed brachytherapy in renal transplant recipients: An analysis of oncological outcomes and toxicity profile - Abstract June 13, 2014

Dorsal penile nerve block for robot-assisted radical prostatectomy catheter related pain: A randomized, double-blind, placebo-controlled trial - Abstract June 13, 2014

Health-related quality of life in the first year after laparoscopic radical prostatectomy compared with open radical prostatectomy - Abstract June 13, 2014

Differences in major depressive disorder and generalised anxiety disorder symptomatology between prostate cancer patients receiving hormone therapy and those who are not - Abstract June 13, 2014

Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS) - Abstract June 13, 2014

Emerging therapeutic for the treatment of skeletal-related events associated with metastatic castrate-resistant prostate cancer - Abstract June 13, 2014

Evaluation of the clinical usefulness of a health-related Quality of Life Questionnaire in patients with prostate cancer - Abstract June 13, 2014

Prostate cancer antigen 3 test for prostate biopsy decision: A systematic review and meta analysis - Abstract June 13, 2014

American Cancer Society prostate cancer survivorship care guidelines - Abstract June 12, 2014

Traditional androgen ablation approaches to advanced prostate cancer: New insights - Abstract June 12, 2014

Utility of LHRH antagonists for advanced prostate cancer - Abstract June 12, 2014

Real-time elastography in the diagnosis of patients suspected of having prostate cancer: A meta-analysis - Abstract June 12, 2014

The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer - Abstract June 12, 2014

Beta-blocker usage and prostate cancer survival: A nested case-control study in the UK Clinical Practice Research Datalink cohort - Abstract June 11, 2014

User-centered design of quality of life reports for clinical care of patients with prostate cancer - Abstract June 11, 2014

A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients - Abstract June 11, 2014

Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy - Abstract June 11, 2014

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity - Abstract June 11, 2014

Response to subsequent docetaxel in a patient cohort with metastatic castration-resistant prostate cancer after abiraterone acetate treatment - Abstract June 11, 2014

The changing landscape of advanced and castration resistant prostate cancer: Latest science and revised definitions - Abstract June 11, 2014

Page 1020 of 1435